Slideshow
Author(s):
A new study has found that patients with neuropsychiatric systemic lupus erythematosus have 3 times increased risk of death, and this risk increases to over 7 times higher in patients with focal CNS symptoms.
NeuroVoices: Joseph Kuchling, MD, on Bridging Gaps in Autoimmune Condition Overlap With New MS Diagnostic Criteria
Episode 125: Understanding Major Changes to New McDonald Criteria for Multiple Sclerosis
Challenges and Opportunities Bringing Lecanemab to Neurology Community Clinics
Episode 124: Therapeutic Updates and Progress in Treating Becker Muscular Dystrophy
PTC to Submit NDA for Vatiquinone in Friedreich Ataxia Following Positive Long-Term Extension Data
FDA Grants Orphan Drug Designation to Becker and Duchenne Agent RAG-18